Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.
Henry de Traux de WardinRonald A GhosseinJosephine Kam Tai K DermawanMariel H SmithSuzanne L WoldenCristina R AntonescuLeonard H WexlerPublished in: JCO precision oncology (2023)
Our data provide rationale for considering the integration of molecular abnormalities to refine risk stratification in extremity RMS.